Irritable Bowel Syndrome Treatment Market Size, Share, And Growth Report 2032

Irritable Bowel Syndrome Treatment Market Size

The global Irritable Bowel Syndrome Treatment market size was worth around USD 3.77 billion in 2023 and is predicted to grow to around USD 7.91 billion by 2032 with a compound annual growth rate (CAGR) of roughly 8.6% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Irritable Bowel Syndrome Treatment market on a global and regional level.

Request Free Sample

Irritable Bowel Syndrome Treatment Market: Overview

Irritable Bowel Syndrome (IBS) is a disorder that disturbs the large intestine. The symptoms of IBS comprise abdominal pain, cramping, gas, constipation or diarrhea, and bloating. IBS management is a long term process. Mild symptoms can be controlled by handling lifestyle, diet, and stress. However, severe symptoms require counseling and medication. IBS with diarrhea (IBS-D) and IBS with constipation (IBS-C) are two major types of IBS.

Factors such as increasing prevalence of IBS, growing use of medication for the treatment of IBS, increasing commercialization of available drugs in multiple regions, and increasing trend of unhealthy lifestyle will act as major driving factors in the growth of global irritable bowel syndrome treatment market. Launch of new products and investment in research and development will act as an opportunity for the market players in the irritable bowel syndrome treatment market. Nonetheless, lack of awareness and dearth of skilled physicians in low-income countries will restrict the growth of global irritable bowel syndrome treatment market.

The study includes drivers and restraints for the irritable bowel syndrome treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the irritable bowel syndrome treatment market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the irritable bowel syndrome treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product and services segment is benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the irritable bowel syndrome treatment market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the irritable bowel syndrome treatment market on global and regional basis.

Irritable Bowel Syndrome Treatment Market: Segmentation

The global irritable bowel syndrome treatment market has been split into product, type, and region.

Based on product, irritable bowel syndrome treatment market has been segmented into constella/linzess, amitiza, xifaxan, viberzi, and others. The constella/linzess segment accounted for the highest market share in 2023 due to increasing acceptance of the product.

The type segment has been segmented into IBS-D and IBS-C. The IBS-C segment accounted for the highest market share in 2023 due to high prevalence of IBS-C. IBS-D has been divided into viberzi, xifaxan, and others. IBS-C has been divided into amitiza, constella/linzess, and others.

Irritable Bowel Syndrome Treatment Market: Report Scope

Irritable Bowel Syndrome Treatment Market: Regional Analysis

North America will be the leading region during the forecast period. Presence of major companies, presence of modern healthcare infrastructure, and availability of novel treatment options will boost the market growth in this region. Europe is expected to be the second major market.

Request Free Sample

The key reasons are presence of skilled physicians and high healthcare expenditure. Asia Pacific will grow at rapid rate over the forecast time-frame due to launch of novel products, increasing patient awareness, growing government initiatives. The market in Latin America will grow at a substantial rate during the estimate period. The Africa and Middle Eastern region is expected to exhibit definite progression in the anticipated time-frame.

Irritable Bowel Syndrome Treatment Market: Competitive Analysis

The report also includes detailed profiles of key players such as:

• Allergan
• Ironwood Pharmaceuticals Inc.
• Astellas Pharma Inc.
• AstraZeneca
• Takeda Pharmaceutical Company Limited
• Synergy Pharmaceuticals Inc.
• Sebela Pharmaceuticals Inc.
• Ardelyx
• Synthetic Biologics Inc.
• Bausch Health

This report segments the Global Irritable Bowel Syndrome Treatment Market as follows:

Global Irritable Bowel Syndrome Treatment Market: By Product

• Constella/Linzess

• Amitiza
• Xifaxan
• Viberzi
• Others

Global Irritable Bowel Syndrome Treatment Market: By Type

• IBS-D

  • Viberzi
  • Xifaxan
  • Others
• IBS-C
  • Amitiza
  • Constella/Linzess
  • Others

Global Irritable Bowel Syndrome Treatment Market: By Region

• North America

  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa